Brief: Omega Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results And Outlines Key Corporate Objectives For 2022
10/03/2022 12:30
March 10 (Reuters) - Omega Therapeutics Inc OMGA.O :
* OMEGA THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2021
FINANCIAL RESULTS AND OUTLINES KEY CORPORATE OBJECTIVES FOR 2022
* OMEGA THERAPEUTICS INC - NET LOSS FOR Q4 OF 2021 WAS $20.9
MILLION, COMPARED WITH $9.5 MILLION
Source text for Eikon: ID:nPn7Y0Nvta
Further company coverage: OMGA.O
Recent news on Omega Liquidating
See all newsBrief: Omega Therapeutics Files For Chapter 11 Bankruptcy In U.S. - Court Filing
Brief: Omega Therapeutics Announces Entry Into New Financing Facilities To Fund Sale Process And Wind Down Of Any Remaining Co Assets
Brief: Omega Therapeutics Receives Notice Of Default Under The Loan And Security Agreement Between Company And Banc Of California
U.S. RESEARCH ROUNDUP- Applied Materials, Disney, Walmart
Brief: Flagship Pioneering Announces Appointment Of Junaid Bajwa As Senior Partner, Head Of United Kingdom, And Science Partner For Pioneering Intelligence